COST EFFECTIVE FORMULATION DEVELOPMENT OF ROSUVASTATIN IN COMPARED TO INNOVATOR BRAND & EVALUATION OF INTERCHANGEABILITY VIA IN-VITRO BIO-EQUIVALENCE STUDY

Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 11

Abstract

Generic Rosuvastatin formulation has been developed which is comparatively cost-effective as well as bio-similar in efficacy in compared with the Brand drug Crestor (Rosuvastatin). Research shows that overpriced medicines causes huge national burden and health care expenses has gone out of control. A Study results shows that millions of adults patients skip over medications to buy due to their high cost (Robin A. Cohen, Maria A. Villarroel, NCSH Researchers. 2013).[1] Research also found that patients are used to save money on drugs costs and they asked doctors for lower-cost medications, buying prescription drugs from other countries and using alternative therapies. So, high drugs costs problems can be handled by development of cost-effective generic drugs with same therapeutic efficacy or bio-similar to brand name drugs. According to US. FDA - a generic medicine give the identical clinical benefit and works in the same way like other brand-name version drugs. This standard applies to all FDA-approved generic medicines in safety, dosage form, strength, quality, route of administration, and intended use”(US FDA 2017).[2] So, with the main focusing of cost-defective formulation development, we have tried to evaluate the overall quality of developed drugs from the points of - dosage form, therapeutic efficacy, strength, safety, route of administration, performance quality, characteristics and intended use. We have conducted an In-Vitro Bio-Equivalence Study to establish the bio-similarity of Generic Rosuvastatin and we have achieved similar results like Brand name Rosuvastatin- Crestor. New developed Generic Rosuvastatin tablets found therapeutically bio-equivalent as the Brand name innovator and more cost-effective than brand drug.

Authors and Affiliations

Farzana Hasin

Keywords

Related Articles

NASAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS CARRIAGE IN PRE AND POST-OPERATIVE PATIENTS IN A TERTIARY HEALTH FACILITY IN UYO, SOUTH-SOUTH, NIGERIA

Methicillin-resistant Staphylococcus aureus is responsible for a greater number of hospital acquired infections which are difficult to treat in humans. Infection increases when unsuspected patients with community-acquire...

THE ROLE OF COSMETIC DENTISTRY IN RESTORING A YOUTHFUL APPEARANCE IN SAUDI POPULATION: AN OVERVIEW

Mouth is a vital organ to express aesthetics in very diverse and distinctive ways. Size and form of the lips, mouth corners, and smile all play significant roles in aesthetics. A smile is a delighted, generous, or charme...

LOCAL SURVEY FOR AWARENESS OF HYPERACIDITY AND/OR OTHER ASSOCIATED PROBLEMS

Awareness for Hyperacidity and associated problems was judged in a population of Worli area of Mumbai during a medical camp held on March 15, 2017 at the campus of M.A. Podar (Govt.) Hospital, Worli, Mumbai-18. As prepar...

EVALUATION OF THE ANTIMICROBIAL EFFECT OF EXPIRED ORAL ANTIBIOTICS IN-VITRO.

Background: In spite of significant risks, as well as non-clinical importance due to loss of potency, stiff penalties against administration of expired antibiotics are still not appropriately enforced by health policy ma...

AN OUTLOOK TO FORM FILL SEAL TECHNOLOGY

Form fill seal (FFS) technology is an automated computer operated technology, to prepare sterile products. Form-fill-seal technology is subject to constant development, a manufacturer requires modern and reliable packagi...

Download PDF file
  • EP ID EP674247
  • DOI -
  • Views 185
  • Downloads 0

How To Cite

Farzana Hasin (2017). COST EFFECTIVE FORMULATION DEVELOPMENT OF ROSUVASTATIN IN COMPARED TO INNOVATOR BRAND & EVALUATION OF INTERCHANGEABILITY VIA IN-VITRO BIO-EQUIVALENCE STUDY. World Journal of Pharmaceutical Research, 6(11), 72-86. https://europub.co.uk/articles/-A-674247